These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15298630)

  • 41. How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.
    Laine L; Goldkind L; Curtis SP; Connors LG; Yanqiong Z; Cannon CP
    Am J Gastroenterol; 2009 Feb; 104(2):356-62. PubMed ID: 19174782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.
    Chitturi S; George J
    Semin Liver Dis; 2002; 22(2):169-83. PubMed ID: 12016548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Non-steroidal anti-inflammatory drugs: predictably nephrotoxic in various groups of patients].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1991 Mar; 135(12):535. PubMed ID: 2027401
    [No Abstract]   [Full Text] [Related]  

  • 45. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.
    Hooper L; Brown TJ; Elliott R; Payne K; Roberts C; Symmons D
    BMJ; 2004 Oct; 329(7472):948. PubMed ID: 15475342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatotoxicity induced by coxibs: how concerned should we be?
    Bessone F; Hernandez N; Roma MG; Ridruejo E; Mendizabal M; Medina-Cáliz I; Robles-Díaz M; Lucena MI; Andrade RJ
    Expert Opin Drug Saf; 2016 Nov; 15(11):1463-1475. PubMed ID: 27537326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic.
    De Valle MB; Av Klinteberg V; Alem N; Olsson R; Björnsson E
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1187-95. PubMed ID: 17014577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of hepatitis induced by non-steroidal anti-inflammatory drugs (NSAID).
    Trechot P; Gillet P; Gay G; Hanesse B; Netter P; Castot A; Larrey D
    Ann Rheum Dis; 1996 Dec; 55(12):936. PubMed ID: 9014594
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatotoxicity of anti-inflammatory and analgesic drugs: ultrastructural aspects.
    Manov I; Motanis H; Frumin I; Iancu TC
    Acta Pharmacol Sin; 2006 Mar; 27(3):259-72. PubMed ID: 16490160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hepatitis secondary to current non-steroidal anti-inflammatory agents].
    Hannequin JR; Doffoel M; Schmutz G
    Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):983-8. PubMed ID: 3070713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Old and new antirheumatic drugs and the risk of hepatotoxicity.
    Anelli MG; Scioscia C; Grattagliano I; Lapadula G
    Ther Drug Monit; 2012 Dec; 34(6):622-8. PubMed ID: 23128910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug-induced liver damage caused by antirheumatic drugs--antirheumatic therapy in pre-existing liver damage].
    Breithaupt H
    Z Rheumatol; 1994; 53(4):250-4. PubMed ID: 7975937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis and non-steroidal anti-inflammatory drugs.
    Doube A
    Ann Rheum Dis; 1990 Jul; 49(7):489-90. PubMed ID: 2200358
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.
    Utzeri E; Usai P
    World J Gastroenterol; 2017 Jun; 23(22):3954-3963. PubMed ID: 28652650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin.
    Taha AS; Angerson WJ; Prasad R; McCloskey C; Blatchford O
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1171-8. PubMed ID: 17894659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease.
    Carson JL; Strom BL; Duff A; Gupta A; Das K
    Arch Intern Med; 1993 Jun; 153(11):1331-6. PubMed ID: 8507123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug- and herb-induced liver injury: a case series from a single center.
    Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A
    Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adverse effects of non-steroidal anti-inflammatory drugs].
    Guzecka E; Czarnecki A
    Pol Tyg Lek; 1988 Jul; 43(29):931-6. PubMed ID: 2976932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.